Life Sciences

News
Medicxi co-founder and partner Francesco De Rubertis

Medicxi primes its latest $400m biotech fund

Anglo-Swiss life sciences investment company Medicxi has raised $400 million for its fourth fund, which will focus on supporting 'asset-centric' companies at all stages of

Sales & Marketing
12 Questions with Chih Han Chen

12 Questions with Chih Han Chen

Chih Han Chen is a distinguished leader with a strong footing in data science and AI for the life sciences sector.